A study comparing cadmium concentrations in tissue, blood, and urine of malignant and benign breast cancer patients showed that cadmium levels were significantly higher in patients with malignant tumors than those with benign tumors and that ERα-positive breast cancers had significantly higher cadmium concentrations than ERα-negative cancers5. Here, ESR1 is linked to breast cancer.